Our group has recently shown that, additionally to NE, also PR3 plays an important role in the development of obesity-induced NAFLD and insulin resistance in a mouse model for obesity-induced NAFLD [18]. The gene discussed is PRTN3; the disease is metabolic dysfunction-associated steatotic liver disease.